MedDataX Logo

Comparison of Two Different Treatment Methods

NCT ID: NCT05071469

Last Updated: 2022-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-28

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subacromial Impingement Syndrome Musculoskeletal Diseases Musculoskeletal Injury Musculoskeletal Pain Weakness, Muscle

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Subacromial Impingement Syndrome Mulligan Mobilization Technique Kinesiotaping Physiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Single

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group (CG)

Control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Kinesiotaping Group (KG)

Experimental group

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type OTHER

KT was applied.

Mulligan Mobilization Technique Group (MG)

Experimental group (2)

Group Type EXPERIMENTAL

Mulligan Mobilization Technique

Intervention Type OTHER

MMT was applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

KT was applied.

Intervention Type OTHER

Mulligan Mobilization Technique

MMT was applied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Impingement symptoms in clinical tests
* Pain \>1 month

Exclusion Criteria

* Any shoulder pathology.
* Have chronic systemic diseases or infections.
* History of any surgery shoulder complex.
* steroid injections and therapeutic approaches
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muğla Sıtkı Koçman University

OTHER

Sponsor Role collaborator

Banu BAYAR

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Banu BAYAR

Principal investigator, Head of Physiotherapy and Rehabilitation Department, Pt. PhD. Prof.

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Muğla Sıtkı Koçman University

Muğla, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

180030/16

Identifier Type: -

Identifier Source: org_study_id